Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [383]
News [1134]
Articles [113]
Editorials [6]
Conferences [69]
elearning [19]
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
2 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma...
Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013
Next generation PI3 kinase inhibition
Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013
Targeting tumour suppressor genes
Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013
Robotic oesophagectomy
Dr Kemp Kernstine - University of Texas Southwestern Medical Center, United...
Robotic oesophagectomy ( Dr Kemp Kernstine - University of Texas Southwestern Medical Center, United States )
19 Dec 2012
Benefits of partaking in clinical trials
Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS...
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK )
15 Nov 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012
The first phase II trial for the management of oesophageal cancer
Prof David Ferry – New Cross Hospital, Wolverhampton, UK
The first phase II trial for the management of oesophageal cancer ( Prof David Ferry – New Cross Hospital, Wolverhampton, UK )
8 Oct 2012
Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy
Prof David Ferry - New Cross Hospital, Wolverhampton, UK
Gefitinib versus placebo in oesophageal cancer progressing after chemotherapy ( Prof David Ferry - New Cross Hospital, Wolverhampton, UK )
29 Sep 2012
Landscape of cancer care in Bangladesh
Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh
Landscape of cancer care in Bangladesh ( Dr Akram Hussain Syed – University Hospital Dhaka, Bangladesh )
20 Jul 2012
Importance of cancer prevention
Prof Murat Tuncer - Hacettepe University, Ankara, Turkey
Importance of cancer prevention ( Prof Murat Tuncer - Hacettepe University, Ankara, Turkey )
20 Jul 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation